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The roots of Clostridium difficile in pediatrics are deep, tracing back to the discovery of 24 the organism. Hall and O'Toole first described the organism as part of the normal flora in 25 neonates naming it Bacillus difficilis (1). Much knowledge has since been gained about C. 26 difficile with its pathogenic potential ranging from asymptomatic carriage to mild diarrhea, 27 severe colitis, and toxic megacolon. It is well recognized that C. difficile infection (CDI) is a 28 leading cause of nosocomial and antibiotic associated illness in adults, posing a huge burden on 29 the healthcare system, and thus is a major public health concern. Concomitant to the increase of 
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While in most instances detection of C. difficile in infants will be non-contributory to 90 diarrheal illness and represents colonization, there are rare cases of C. difficile associated deaths 91 in this age group (15). In a study by Kim et. al. , the authors noted that 26% of the reported C. 
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In this study, the laboratory data for the type of test used for diagnosis or confirmation of CDI 112 were not available. Therefore, the differences in the performance characteristics of the various 113 methodologies for the detection of CDI in children in these high risk populations were not 114 assessed. In a separate study assessing risk factors for children with recurring CDI, malignancy, 115 recent surgery, and antibiotic exposure were the most significant factors (18). Both enzyme 116 immunoassays (EIA) and nucleic acid amplification tests (NAAT) were used as laboratory tests 117 for the detection of C. difficile, however, no data were presented on the differences in test 118 performance. Solid organ transplantation also appears to be a risk factor for a higher incidence 119 of CDI in children, especially those between 1-4 years of age (19).
120
As with infants, high rates of asymptomatic colonization have been 
C. difficile Diagnostic Tests
A number of laboratory tests are available to aid in the diagnosis of CDI. They differ in 220 what is being detected with some identifying the presence of the bacteria, some detecting the 221 presence of toxins, and some detecting nucleic acid for genes associated with toxin production.
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All of the tests described below can be used both in adult and pediatric patients. It is important to 223 understand the differences in these methods and the clinical implications for a positive result in for the most accurate prediction of disease (33). The study included patients older than 2 years, 293 but the pediatric patients were not analyzed separately; therefore, the predictive value of a 294 positive EIA for assessing disease in these patients is still unknown. 
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Outcomes of Clostridium difficile infection in pediatric solid organ transplant recipients. 
